IDENTIFICATION OF AN ENDOGENOUS 2-MONOGLYCERIDE, PRESENT IN CANINE GUT, THAT BINDS TO CANNABINOID RECEPTORS

被引:2204
作者
MECHOULAM, R
BENSHABAT, S
HANUS, L
LIGUMSKY, M
KAMINSKI, NE
SCHATZ, AR
GOPHER, A
ALMOG, S
MARTIN, BR
COMPTON, DR
PERTWEE, RG
GRIFFIN, G
BAYEWITCH, M
BARG, J
VOGEL, Z
机构
[1] MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824
[2] CHAIM SHEBA MED CTR,INST CLIN PHARMACOL & TOXICOL,IL-52621 TEL HASHOMER,ISRAEL
[3] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
[4] UNIV ABERDEEN,MARISCHAL COLL,DEPT BIOMED SCI,ABERDEEN AB9 1AS,SCOTLAND
[5] WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL
基金
英国惠康基金;
关键词
2-ARACHIDONYL GLYCEROL; ANAND AMIDE; TETRAHYDROCANNABINOL; ARACHIDONYLETHANOLAMIDE; IMMUNE SYSTEM; TRANSFECTION; MOUSE BEHAVIOR; ADENYLATE CYCLASE INHIBITION;
D O I
10.1016/0006-2952(95)00109-D
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl). Its structure was determined by mass spectrometry and by direct comparison with a synthetic sample. 2-Ara-Gl bound to membranes from cells transiently transfected with expression plasmids carrying DNA of either CB1 or CB2-the two cannabinoid receptors identified thus far-with K-i values of 472 +/- 55 and 1400 +/- 172 nM, respectively. In the presence of forskolin, 2-Ara-Gl inhibited adenylate cyclase in isolated mouse spleen cells, at the potency level of Delta(9)-tetrahydrocannabinol (Delta(9)-THC). Upon intravenous administration to mice, 2-Ara-Gl caused the typical tetrad of effects produced by THC: antinociception, immobility, reduction of spontaneous activity, and lowering of the rectal temperature. 2-Ara-Gl also shares the ability of Delta(9)-THC to inhibit electrically evoked contractions of mouse isolated vasa deferentia; however, it was less potent than Delta(9)-THC.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 37 条
[1]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[2]  
CABRAL GA, 1991, ADV EXP MED BIOL, V288, P93
[3]   EFFECTS OF ANANDAMIDE ON CANNABINOID RECEPTORS IN RAT-BRAIN MEMBRANES [J].
CHILDERS, SR ;
SEXTON, T ;
ROY, MB .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (04) :711-715
[4]  
COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218
[5]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201
[6]   ENZYMATIC-SYNTHESIS AND DEGRADATION OF ANANDAMIDE, A CANNABINOID RECEPTOR AGONIST [J].
DEUTSCH, DG ;
CHIN, SA .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (05) :791-796
[7]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[8]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[9]  
DEWEY WL, 1970, J PHARMACOL EXP THER, V175, P435
[10]   ANANDAMIDE, AN ENDOGENOUS CANNABIMIMETIC EICOSANOID, BINDS TO THE CLONED HUMAN CANNABINOID RECEPTOR AND STIMULATES RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION [J].
FELDER, CC ;
BRILEY, EM ;
AXELROD, J ;
SIMPSON, JT ;
MACKIE, K ;
DEVANE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7656-7660